Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06942000
PHASE3

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery decreases the incidence of shivering associated with spinal anesthesia

Official title: Efficacy of Dexmedetomidine as Adjuvant to Intrathecal Bupivacaine in Decreasing Incidence of Post-spinal Shivering in Pregnant Women Undergoing Cesarean Section.

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-05-01

Completion Date

2025-12-30

Last Updated

2025-04-24

Healthy Volunteers

No

Interventions

DRUG

dexmedetomidine 3mcg group

3mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

dexmedetomidine 5mcg

5mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

preservative-free 0.9% saline.

(0.5 ml) preservative-free 0.9% saline

Locations (2)

Faculty of Medicine, Al-Azhar University, Assiut, Egypt

Asyut, Egypt

Mohamed Ali Mahmoud

Asyut, Egypt